These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 18254957)
21. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling. Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634 [TBL] [Abstract][Full Text] [Related]
22. CAML promotes prolactin-dependent proliferation of breast cancer cells by facilitating prolactin receptor signaling pathways. Lim JH; Kim TY; Kim WH; Park JW Breast Cancer Res Treat; 2011 Nov; 130(1):19-27. PubMed ID: 21128111 [TBL] [Abstract][Full Text] [Related]
23. Prolactin receptor-integrin cross-talk mediated by SIRPα in breast cancer cells. Galbaugh T; Feeney YB; Clevenger CV Mol Cancer Res; 2010 Oct; 8(10):1413-24. PubMed ID: 20826546 [TBL] [Abstract][Full Text] [Related]
24. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling. García-Martínez JM; Calcabrini A; González L; Martín-Forero E; Agulló-Ortuño MT; Simon V; Watkin H; Anderson SM; Roche S; Martín-Pérez J Cell Signal; 2010 Mar; 22(3):415-26. PubMed ID: 19892015 [TBL] [Abstract][Full Text] [Related]
25. Stat5 activation inhibits prolactin-induced AP-1 activity: distinct prolactin-initiated signals in tumorigenesis dependent on cell context. Gutzman JH; Rugowski DE; Nikolai SE; Schuler LA Oncogene; 2007 Sep; 26(43):6341-8. PubMed ID: 17438530 [TBL] [Abstract][Full Text] [Related]
26. Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor. Dif F; Saunier E; Demeneix B; Kelly PA; Edery M Endocrinology; 2001 Dec; 142(12):5286-93. PubMed ID: 11713228 [TBL] [Abstract][Full Text] [Related]
27. Mechanisms underlying the diminished sensitivity to prolactin negative feedback during lactation: reduced STAT5 signaling and up-regulation of cytokine-inducible SH2 domain-containing protein (CIS) expression in tuberoinfundibular dopaminergic neurons. Anderson ST; Barclay JL; Fanning KJ; Kusters DH; Waters MJ; Curlewis JD Endocrinology; 2006 Mar; 147(3):1195-202. PubMed ID: 16357045 [TBL] [Abstract][Full Text] [Related]
28. Cyclophilin B as a co-regulator of prolactin-induced gene expression and function in breast cancer cells. Fang F; Zheng J; Galbaugh TL; Fiorillo AA; Hjort EE; Zeng X; Clevenger CV J Mol Endocrinol; 2010 Jun; 44(6):319-29. PubMed ID: 20237142 [TBL] [Abstract][Full Text] [Related]
29. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase. Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625 [TBL] [Abstract][Full Text] [Related]
30. Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5. Pezet A; Ferrag F; Kelly PA; Edery M J Biol Chem; 1997 Oct; 272(40):25043-50. PubMed ID: 9312112 [TBL] [Abstract][Full Text] [Related]
31. Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors. Bogorad RL; Courtillot C; Mestayer C; Bernichtein S; Harutyunyan L; Jomain JB; Bachelot A; Kuttenn F; Kelly PA; Goffin V; Touraine P; Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14533-8. PubMed ID: 18779591 [TBL] [Abstract][Full Text] [Related]
32. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway. Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813 [TBL] [Abstract][Full Text] [Related]
33. Activation of farnesoid X receptor increases the expression of cytokine inducible SH2-containing protein in HepG2 cells. Xu Z; Huang G; Gong W; Zhao Y; Zhou P; Zeng Y; He F J Interferon Cytokine Res; 2012 Nov; 32(11):517-23. PubMed ID: 22817871 [TBL] [Abstract][Full Text] [Related]
35. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation. Endo T; Sasaki A; Minoguchi M; Joo A; Yoshimura A J Biochem; 2003 Jan; 133(1):109-13. PubMed ID: 12761205 [TBL] [Abstract][Full Text] [Related]
36. Prolactin/Stat5 and androgen R1881 coactivate carboxypeptidase-D gene in breast cancer cells. Koirala S; Thomas LN; Too CK Mol Endocrinol; 2014 Mar; 28(3):331-43. PubMed ID: 24433040 [TBL] [Abstract][Full Text] [Related]
37. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription. Ferrag F; Chiarenza A; Goffin V; Kelly PA Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989 [TBL] [Abstract][Full Text] [Related]
38. Methionine promotes crop milk protein synthesis through the JAK2-STAT5 signaling during lactation of domestic pigeons (Columba livia). Chen MJ; Pan NX; Wang XQ; Yan HC; Gao CQ Food Funct; 2020 Dec; 11(12):10786-10798. PubMed ID: 33232416 [TBL] [Abstract][Full Text] [Related]
39. Cross-talk between signal transducer and activator of transcription (Stat5) and thyroid hormone receptor-beta 1 (TRbeta1) signaling pathways. Favre-Young H; Dif F; Roussille F; Demeneix BA; Kelly PA; Edery M; de Luze A Mol Endocrinol; 2000 Sep; 14(9):1411-24. PubMed ID: 10976919 [TBL] [Abstract][Full Text] [Related]
40. Augmented Stat5 Signaling Bypasses Multiple Impediments to Lactogen-Mediated Proliferation in Human β-Cells. Chen H; Kleinberger JW; Takane KK; Salim F; Fiaschi-Taesch N; Pappas K; Parsons R; Jiang J; Zhang Y; Liu H; Wang P; Bender AS; Frank SJ; Stewart AF Diabetes; 2015 Nov; 64(11):3784-97. PubMed ID: 26159175 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]